Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Whitney B Pope

Showing results (91-100 of 128) with videos related to

Pageof 13
Sort By:
Molecular Imaging and Biology|December 4, 2014
Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant GliomasElena Karavaeva, Robert J Harris, Kevin Leu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 11, 2020
Voxelwise and Patientwise Correlation of <sup>18</sup>F-FDOPA PET, Relative Cerebral Blood Volume, and Apparent Diffusion Coefficient in Treatment-Naïve Diffuse Gliomas with Different Molecular SubtypesHiroyuki Tatekawa, Akifumi Hagiwara, Jingwen Yao, et al.
Scientific Reports|January 21, 2022
Visualization of tumor heterogeneity and prediction of isocitrate dehydrogenase mutation status for human gliomas using multiparametric physiologic and metabolic MRIAkifumi Hagiwara, Hiroyuki Tatekawa, Jingwen Yao, et al.
AJNR. American Journal of Neuroradiology|January 18, 2024
Quantification of T2-FLAIR Mismatch in Nonenhancing Diffuse Gliomas Using Digital SubtractionNicholas S Cho, Francesco Sanvito, Viên Lam Le, et al.
Neuroradiology|October 8, 2024
Diffusion MRI is superior to quantitative T2-FLAIR mismatch in predicting molecular subtypes of human non-enhancing gliomasNicholas S Cho, Francesco Sanvito, Viên Lam Le, et al.
Radiology|June 30, 2009
Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatmentWhitney B Pope, Hyun J Kim, Jing Huo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Relationship between survival and edema in malignant gliomas: role of vascular endothelial growth factor and neuronal pentraxin 2Marc R J Carlson, Whitney B Pope, Steve Horvath, et al.
Journal of Neuro-Oncology|September 15, 2020
Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-naïve diffuse gliomasHiroyuki Tatekawa, Akifumi Hagiwara, Hiroyuki Uetani, et al.
Journal of Neuro-Oncology|March 11, 2021
Preferential tumor localization in relation to <sup>18</sup>F-FDOPA uptake for lower-grade gliomasHiroyuki Tatekawa, Hiroyuki Uetani, Akifumi Hagiwara, et al.
Scientific Reports|September 10, 2020
Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastomaKunal S Patel, Jingwen Yao, Catalina Raymond, et al.
Pageof 13

Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Molecular Imaging and Biology|December 4, 2014
Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant GliomasElena Karavaeva, Robert J Harris, Kevin Leu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 11, 2020
Voxelwise and Patientwise Correlation of <sup>18</sup>F-FDOPA PET, Relative Cerebral Blood Volume, and Apparent Diffusion Coefficient in Treatment-Naïve Diffuse Gliomas with Different Molecular SubtypesHiroyuki Tatekawa, Akifumi Hagiwara, Jingwen Yao, et al.
Scientific Reports|January 21, 2022
Visualization of tumor heterogeneity and prediction of isocitrate dehydrogenase mutation status for human gliomas using multiparametric physiologic and metabolic MRIAkifumi Hagiwara, Hiroyuki Tatekawa, Jingwen Yao, et al.
AJNR. American Journal of Neuroradiology|January 18, 2024
Quantification of T2-FLAIR Mismatch in Nonenhancing Diffuse Gliomas Using Digital SubtractionNicholas S Cho, Francesco Sanvito, Viên Lam Le, et al.
Neuroradiology|October 8, 2024
Diffusion MRI is superior to quantitative T2-FLAIR mismatch in predicting molecular subtypes of human non-enhancing gliomasNicholas S Cho, Francesco Sanvito, Viên Lam Le, et al.
Radiology|June 30, 2009
Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatmentWhitney B Pope, Hyun J Kim, Jing Huo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Relationship between survival and edema in malignant gliomas: role of vascular endothelial growth factor and neuronal pentraxin 2Marc R J Carlson, Whitney B Pope, Steve Horvath, et al.
Journal of Neuro-Oncology|September 15, 2020
Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-naïve diffuse gliomasHiroyuki Tatekawa, Akifumi Hagiwara, Hiroyuki Uetani, et al.
Journal of Neuro-Oncology|March 11, 2021
Preferential tumor localization in relation to <sup>18</sup>F-FDOPA uptake for lower-grade gliomasHiroyuki Tatekawa, Hiroyuki Uetani, Akifumi Hagiwara, et al.
Scientific Reports|September 10, 2020
Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastomaKunal S Patel, Jingwen Yao, Catalina Raymond, et al.
Pageof 13